J Refract Surg. 2014 Jul;30(7):462-6. doi: 10.3928/1081597X-20140521-02. Epub 2014 May 28.
To evaluate the effect of MyoRing implantations (DIOPTEX GmbH, Linz, Austria) in patients with ectasia after LASIK.
MyoRing implantation was performed in 15 eyes of 14 patients with ectasia after LASIK using a femtosecond laser. Uncorrected and corrected distance visual acuity, refraction, keratometry, central corneal thickness, corneal biomechanical profile, and corneal aberrometry were evaluated preoperatively and at 1, 3, and 6 months, and 1 year postoperatively.
Uncorrected distance visual acuity (1.02 ± 0.48 to 0.30 ± 0.18 logMAR), maximum keratometry (50.14 ± 1.82 to 43.80 ± 1.21 diopters), and sphere (-4.4 ± 4.8 to +1.50 ± 0.61 diopters) were significantly improved from preoperative values at 1 month after surgery with no significant change afterward. Corrected distance visual acuity did not improve significantly 1 month after implantation, but between the 1- and 3-month follow-up visits, a significant improvement (0.30 ± 0.1 to 0.17 ± 0.13 logMAR) was observed without any additional improvement thereafter. A nearly significant (P = .05) increase in central corneal thickness (439.4 ± 19 to 452.2 ± 20 μm) was observed during the 1-month postoperative period. Primary coma, higher-order aberrations, and trefoil showed an insignificant decrease 1 month after surgery and afterward. Spherical aberration significantly increased between the preoperative visit and the first postoperative visit. Corneal hysteresis and corneal resistance factor showed no significant change between visits.
MyoRing is a safe and effective method in patients with ectasia after LASIK. It can improve corrected distance visual acuity and reduce refractive error in these patients.
评估 MyoRing 植入物(奥地利林茨的 DIOPTEX GmbH)在 LASIK 后扩张患者中的效果。
使用飞秒激光对 14 名 LASIK 后扩张患者的 15 只眼进行 MyoRing 植入。在术前以及术后 1、3、6 个月和 1 年,评估未矫正和矫正的远距视力、屈光度、角膜曲率计、中央角膜厚度、角膜生物力学特征和角膜像差。
术后 1 个月,未矫正远距视力(1.02±0.48 至 0.30±0.18 logMAR)、最大角膜曲率计(50.14±1.82 至 43.80±1.21 屈光度)和球镜(-4.4±4.8 至 +1.50±0.61 屈光度)与术前相比显著改善,此后无明显变化。植入术后 1 个月,矫正远距视力无明显改善,但在 1 至 3 个月的随访中,观察到显著改善(0.30±0.1 至 0.17±0.13 logMAR),此后无进一步改善。在术后 1 个月期间,中央角膜厚度(439.4±19 至 452.2±20 μm)几乎显著增加(P=0.05)。术后 1 个月,初级彗差、高阶像差和三叶形像差无明显下降,此后则无变化。球差在术前和首次术后检查之间显著增加。角膜滞后和角膜阻力因子在随访中无明显变化。
MyoRing 是 LASIK 后扩张患者的一种安全有效的方法。它可以提高这些患者的矫正远距视力并降低屈光不正。